Remember meForgot password?
    Log in with Twitter

Novartis News

Greek anarchists smash Novartis office amid bribe scandal

Atenas - A Greek anarchist group attacked the Athens headquarters of Novartis on Sunday, Greek police said, amid bribery allegations against the Swiss pharmaceutical giant.

Greek MPs launch probe into Novartis scandal

Atenas - Greece's parliament on Thursday launched a probe into claims that nearly a dozen senior politicians received bribes from or helped promote Swiss pharmaceutical giant Novartis during their term in office.

Greek MPs to back probe into Novartis bribes

Atenas - Greece's parliament was early Thursday to approve a probe into whether nearly a dozen senior politicians received bribes from or helped promote Swiss pharmaceutical giant Novartis during their term in office.

Asthma pill could provide relief for adults with severe asthma

London - A pill that uses a "twin attack" in treating asthma symptoms could soon become available for adults with severe asthma if further studies continue to go well.

Mixed news for Novartis

Pharmaceutical company Novartis experienced mixed results during the first quarter of 2016. Sales showed a decline, however the company is preparing to launch a significant new anti-seizure medication.

U.S. government continues action against drugs firm Norvatis

The U.S. government is seeking documents from the pharmaceutical company Novartis. This is for an investigation into the allegation the Swiss company provided so-called ‘kickback’ payments to doctors.

New Alzheimer’s and migraine treatments being developed

Major pharmaceutical companies Amgen and Novartis are to collaborate on novel neuroscience treatments for Alzheimer's disease and migraine.

Novartis forms biotech spin-off called Mereo

Zurich - The pharmaceutical giant Novartis has established a biotech spin-off company called Mereo. The company will be based in the U.K. and it will work on three bespoke investigational drug products.

Mix of successes and failures for Big Pharma

It has been a mixed week for the pharmaceutical sector in terms of drug development, with success for Novartis and disappointing news for Boehringer and Vitae Pharma. Digital Journal reports on the latest news.

Big pharma company makes major purchase

Major pharmaceutical company Novartis has announced that it will take over the privately held Australian and U.S. company Spinifex Pharmaceuticals. This represents further diversification of Novartis’ portfolio.

Big Pharma company steps into wearable devices market

Drugs giant Novartis has stepped into the wearables technology market with an app called ViaOpta, designed for the visually impaired. Established as a prototype, the company this week unveiled modifications.

Big Pharma company accused of blocking eye treatment

Pharmaceutical giant Novartis has been accused by the British Medical Journal of acting in a way to block access to low-cost eye treatment drug. The claim is refuted by Novartis.

New cardiac drug shows real, life-saving promise

Basel - A new drug developed by Swiss pharmaceutical giant Novartis could turn the world of cardiovascular medicine on its head in less than 12 months.

We've seen Google glass, are we ready for Google contact lenses?

Tech giant Google and pharmaceutical company Novartis have announced they are to develop so-called "smart contacts." The technologically-advanced eyewear will monitor blood sugar concentrations in diabetic patients.

India drugs giant rejects Novartis patent accusations

New Delhi - Leading Indian drug company Biocon on Friday rejected allegations by Novartis that it infringed on the Swiss pharmaceutical giant's patent for its blockbuster diabetes drug Galvus.

Novartis replaces top Japan executives over drug trial scandal

Tokyo - Swiss pharmaceutical giant Novartis said on Thursday it was replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators.

Novartis chairman rules out merger with Roche: paper

Swiss pharma group Novartis <NOVN.VX> will work more closely with rival Roche <ROG.VX> but rules out a merger, its chairman said in a newspaper interview on Sunday.

Tokyo prosecutors raid Novartis Japan offices in probe

Prosecutors in Tokyo raided offices of Swiss drugmaker Novartis <NOVN.VX> on Wednesday as part of an investigation into alleged use of manipulated data to promote its best-selling blood pressure drug Diovan.

Swiss pharma giant Novartis slashes chairman pay

Geneva - Swiss pharmaceutical giant Novartis is preparing to slash the pay of its chairman and board, following a push in Switzerland to rein in the bonuses of top executives, according to a report published Tuesday.

Pharma giant Novartis reports profits dip 1.0% in 2013

Z - Swiss pharmaceuticals giant Novartis on Wednesday announced that its net profit fell 1.0 percent in 2013 to $9.2 billion (6.8 billion euros), blaming the impact of unfavourable exchange rates.

Europe levies fines on Johnson & Johnson and Novartis

The European Commission has imposed multi-million euro fines on Johnson & Johnson and Novartis for what it has called "shocking" breaches of competition law.

Op-Ed: India's Supreme Court rejects Pharma giant Novartis' patent claim

New Delhi - The Supreme Court of India has rejected a plea by Novartis that a patent be granted on an updated version of its drug Glivec. The court ruled that the new version was only slightly different from the old one.

Johnson & Johnson and Novartis breach European antitrust rules

The European Commission is investigating ‘big pharma’ companies Johnson and Johnson and Novartis for a possible breach of antitrust laws.

Cough mixture recalled due to defective ‘child proof’ caps

Cough mixtures distributed in Canada have been recalled by the manufacturer due to the child proof cap proving to be defective. The risk is that a young child could open the medicine bottle.

Novartis Pharma announces major drugs recall

The Swiss pharmaceutical company Novartis has recalled a painkiller medicine from the market: Excedrin, a migraine treatment, from sale in South Africa. This follows an earlier recall of the same medicine in the US.

Drug giant Novartis under investigation following patient deaths

The pharmaceutical company Novartis is under investigation by the European Union following the deaths of 11 patients who took the drug Gilenya.

Drug company recalls Excedrin, Bufferin and other OTC meds

Drug company Novartis Consumer Health, Inc. (NCH) has issued a voluntary recall on several over-the-counter (OTC) medications due to several possible problematic issues.

FDA on Novartis new multiple sclerosis drug -- safe & effective

Silver Spring - Finally the U.S. Food and Drug Administration has approved a pill that it says is both safe and effective for controlling tremors and other symptoms of multiple sclerosis.

Novartis answers H1N1 vaccine shortage, U.S. government pressured

With the Obama administration coming under fire for failing to deliver adequate swine flu vaccinations for the American public, Novartis announces its intention to supply 30 million more doses.

Novartis Defies WHO, Will Not Give Away Swine Flu Vaccine To Poor

A Swiss drug company will not be helping out the poor when it comes to the swine flu, defying the World Health Organization.
  1 2 Next»

Set up a news alert for


Novartis Image

Novartis building  taken on June 12  2006
Novartis building, taken on June 12, 2006
Andrew Hecht
Google lab is making a contact lens to measure glucose in tears.
Google lab is making a contact lens to measure glucose in tears.

Latest News
Top News